Radyasyonun Kadın Fertilitesi Üzerine Etkileri
Özet
Radyoterapi, günümüzde kanser tedavisinin temel yapı taşlarından biri olmakla birlikte, abdominal veya pelvik bölgeye uygulandığında kadın üreme sistemi üzerinde geri dönüşü olmayan, oldukça yıkıcı etkilere yol açabilmektedir. Kadınlar sınırlı ve yenilenemez bir fertilite kapasitesiyle dünyaya geldiklerinden, iyonlaştırıcı radyasyon overlerdeki germ hücrelerinde DNA hasarı oluşturarak folikül havuzunun hızla tükenmesine, erken menopoza ve kısırlığa neden olur. Over rezervinin takibinde AMH, FSH ve antral folikül sayısı gibi tanısal yöntemler kullanılsa da, radyasyonun dozu ve hastanın yaşı hasarın boyutunu doğrudan belirler. Radyasyon yalnızca overleri değil, uterus yapısını da miyometrial ve endometrial fibrozis, atrofi ve vaskülarizasyon bozuklukları yoluyla zedeleyerek embriyo implantasyonunu olumsuz etkiler. Bu durum, tedavi sonrası sağ kalan hastaların gebeliklerinde erken doğum, düşük doğum ağırlığı, plasenta invazyon anomalileri ve uterus rüptürü riskini ciddi oranda artırmaktadır. Bu toksik etkileri engellemek amacıyla cerrahi olarak over transpozisyonu ve uteropeksi gibi teknikler uygulanırken, farmakolojik alanda sfingosin-1-fosfat ve amifostin gibi koruyucu ajanlar geliştirilmektedir. Ayrıca, kranial ışınlamalar hipotalamus-hipofiz-gonadal aksını bozarak hormonal eksikliklere, erken ergenliğe ve hiperprolaktinemiye sebebiyet verebilir. Bu nedenle, genç kanser hastalarında onkofertilite danışmanlığı ve üreme sağlığını koruyucu stratejilerin multidisipliner bir yaklaşımla planlanması hayati önem taşımaktadır.
Although radiotherapy remains a cornerstone in modern oncology, its application to pelvic or abdominal fields can exert profoundly destructive and irreversible effects on the female reproductive system. Since women are born with a finite, non-renewable ovarian reserve, ionizing radiation triggers accelerated cellular apoptosis and DNA double-strand breaks within germ cells, leading to premature ovarian insufficiency and permanent sterility. While diagnostic markers such as Anti-Müllerian Hormone (AMH), FSH, and antral follicle count are critical for assessing remaining ovarian reserve, the patient's age and cumulative radiation dosage remain the primary determinants of injury severity. Beyond ovarian damage, radiation severely compromises uterine integrity by inducing endometrial atrophy, myometrial fibrosis, and microvascular dysfunction, which directly impair embryo implantation. Consequently, cancer survivors face significantly elevated obstetric complications, including spontaneous abortion, preterm delivery, low birth weight, and uterine rupture. To mitigate these adverse outcomes, fertility preservation techniques are essential, incorporating surgical interventions like ovarian transposition and uteropexy, alongside experimental pharmacological shields such as sphingosine-1-phosphate and amifostine. Additionally, cranial irradiation can disrupt the vital hypothalamic-pituitary-gonadal axis, precipitating gonadotropin deficiency, precocious puberty, and hyperprolactinemia. Therefore, early oncofertility counseling and personalized protective management are crucial to safeguarding the future reproductive health and quality of life for young female survivors.
Referanslar
Marci R, Mallozzi M, Di Benedetto L. et al. Radiations and female fertility. Reprod Biol Endocrinol. 2018; 16 (112):1-12.
Cecconi S, Gualtieri G, Di Bartolomeo A, Troiani G, Cifone MG, Canipari R. Evaluation of the effects of extremely low frequency electromagnetic fields on mammalian follicle development. Hum Reprod. 2000; 15(11): 2319–25.
Khaki A, Ranjbar M, Rahimi F, Ghahramanian A. The effects of electromagnetic field (EMFs) on ovary in rat. Ultrasound Obstet Gynecol. 2011;38:269-269.
Lai H, Singh NP. Magnetic-field-induced DNA strand breaks in brain cells of the rat. Environ Health Perspect. 2004; 112(6):687–94.
Roshangar L, Soleimani RJ. Electron microscopic study of folliculogenesis after electromagnetic field exposure. J Reprod Infertil. 2004; 5(4):299–307.
Soleimani Rad J, Rowshangar L, Karimi K. The effect of Electromagnetic field on Fallopian Tube. IFFS 2001 Selected Free Communication, Monduzzi Editore. Moelbourne: International Proceedings Division; 2001. p. 25–30.
Cao YN, Zhang Y, Liu Y. Effects of exposure to extremely low frequency electromagnetic fields on reproduction of female mice and development of offsprings. Chinese Journal of Industrial Hygiene and Occupational Diseases. 2006;24(8):468-470.
Goldhaber MK, Polen MR, Hiatt RA. The risk of miscarriage and birth defects among women who use visual display terminals during pregnancy. Am J Ind Med. 1988;13:695–706
Biedka M, Kuźba-Kryszak T, Nowikiewicz T, Żyromska A. Fertility impairment in radiotherapy. Contemp Oncol (Pozn). 2016; 20(3):199–204.
Baker TG. A quantitative and cytological study of germ cells in human ovaries. Proceedings of the Royal Society of London. Series B. Biological Sciences. 1963;158(972):417-33.
Vaskivuo TE, Anttonen M, Herva R, et al. Survival of human ovarian follicles from fetal to adult life: apoptosism apoptosis-related proteins, and transcription factor GATA-4. J Clin Endocrinol Metab. 2001; 86(7):3421-9.
Abbassi V. Growth and normal puberty. Pediatrics. 1998;102(Supplement_3):507-11.
Lloyd T, Rollings N, Andon MB, et al. Determinants of bone density in young women. Relationships among pubertal development, total body bone mass, and total body bone density in premenarchal females. J Clin Endocrinol Metab. 1992;75(2):383e7
Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB: A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update.2006; 12:685–718.
Esposito MA, Coutifaris C, Barnhart KT: A moderately elevated day 3 FSH concentration has limited predictive value, especially in younger women. Hum Reprod. 2002;17:118–23.
Evers JL, Slaats P, Land JA, Dumoulin JC, Dunselman GA: Elevated levels of basal estradiol-17beta predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization, Fertil Steril. 1998;69:1010–4.
Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009; 91(3):705–14.
Stroud JS, Mutch D, Rader J, Powell M, Thaker PH, Grigsby PW. Effects of cancer treatment on ovarian function. Fertil. Steril. 92(2), 417–427 (2009).
Buyuk E, Nejat E, Neal-Perry G. Determinants of female reproductive senescence: differential roles for the ovary and the neuroendocrine axis. Semin. Reprod. Med. 2010;28(5), 370–379
Ashwood-Smith MJ, Edwards RG. DNA repair by oocytes. Mol Hum Reprod. 1996;2:46–51.
Adriaens I, Smitz J, Jacquet P. The current knowledge on radiosensitivity of ovarian follicle development stages. Hum Reprod Update. 2009;15: 359–77.
Jaroudi S, Kakourou G, Cawood S, et al. Expression profiling of DNA repair genes in human oocytes and blastocysts using microarrays. Hum Reprod. 2009;24: 2649–55.
Wo JY, Viswanathan AN. The impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys. 2009;73:1304–12.
Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod. 2003;18(1):117–21.
Ogilvy-Stuart AL, Shalet SM. Effect of radiation on the human reproductive system. Environ Health Perspect. 1993;101:109–16
Rodriguez-Wallberg KA, OktayK. Options on fertility preservation in female cancer patients. Cancer Treat. Rev. 2012; 38 (5):354–361.
Schuck A, Hamelmann V, Brämswing JH, et al. Ovarian function following pelvic irradiation in prepubertal and pubertal girls and young adult women. Strahelenther Onkol. 2005; 181(8):534–9.
Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013; 31(19):2500–10.
Peigne M, Decanter C. Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic review. Reprod Biol Endocrinol. 2014; 12:26.
Irtan S, Orbach D, Helfre S, Sarnacki S. Ovarian transposition in prepubescent and adolescent girls with cancer. Lancet Oncol. 2013;14(13):e601e8.
Terenziani M, Piva L, Meazza C, Gandola L, Cefalo G, Merola M. Oophoropexy: a relevant role in preservation of ovarian function after pelvic irradiation. Fertil Steril. 2009; 91(3). 935.e15-6.
Bisharah M, Tulandi T. Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol. 2003; 188(2):367e70.].
Lawrenz B, Jauckus J, Kupka MS, Strowitki T, von Wolff M. Fertility preservation in>1,000 patients: patient's characteristics, spectrum, efficacy and risks of applied preservation techniques. Arch Gynecol Obstet. 2011;283(3):651e6.
Fernandez-Pineda I, Davidoff AM, Lu L, et al. Impact of ovarian transposition before pelvic irradiation on ovarian function among long-term survivors of child Hodgkin lymphoma: a report from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer. 2018;65(9):e27232.
Gubbala K, Laios A, Gallos I, Pathiraja P, Haldar K, Ind T. Outcomes of ovarian transposition in gynaecological cancers; a systematic review and meta-analysis. J Ovarian Res. 2014;7(1):1-10.
Lawcett SL, Gomez AC, Barter SJ, Ditchfield M, Set P. More harm than good? The anatomy of misguided shielding of the ovaries. Br J Radiol. 2012;85(1016):e442e7.
Zeliniski MB, Murphy MK, Lawson MS, et al. In vivo delivery of FTY720 prevents radiation-induced ovarian failure and infertility in adult female nonhuman primates. Fertil Steril. 2011;95(4):1440e5.
Mahran YF, El-Demerdash E, Nada AS, Ali AA, Abdel-Naim AB. Insights into the protective mechanisms of tamoxifen in radiotherapy-induced ovarian follicular loss: impact on insulin-like growth factor 1. Endocrinology. 2013;154(10), 3888–99.
Mahran YF, El-Demerdash E, Nada AS, El-Naga RN, Ali AA, Abdel-Naim AB. Growth hormone ameliorates the radiotherapy-induced ovarian follicular loss in rats: impact on oxidative stress, apoptosis and IGF-1/IGF-1R axis. PLoS ONE. 2015;10(10): e0140055
Dziegielewski J, Baulch JE, Goetz W et al. WR-1065, the active metabolite of amifostine, mitigates radiation-induced delayed genomic instability. Free Radic. Biol. Med. 2008;45(12), 1674–1681
Duncan FE, Kimler BF, Briley SM. Combating radiation therapy-induced damage to the ovarian environment. Future Oncol. 2016; 12(14):1687–1690.
Grigsby PW, Russell A, Bruner D, et al. Late injury of cancer therapy on the female reproductive tract. Int J Radiat Oncol Biol Phys. 1995;31:1281–99
Teh WT, Stern C, Chander S, Hickey M. The impact of uterine radiation on subsequent fertility and pregnancy outcomes. Biomed Res Int. 2014;2014:482968.
Dehghan T, Mozdarani H, Khoradmehr A, Kalantar SM. Effects of gamma radiation on fetal development in mice. Int J Reprod Biomed. 2016; 14(4):247–54.
Garg D, Johnstone EB, Lomo L, Fair DB, Rosen MO, Taylor R, Silver B, Letorneau JM. Looking beyond the ovary for oncofertility care in women: uterine injury as a potential target for fertility-preserving treatments. J Assist Reprod Genetics. 2020;37:1467–1476
Bath LE, Critchley HOD, Chambers SE, Anderson RA, Kelnar CJH, Wallace WHB. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. BJOG Int J Obstet Gynaecol. 1999;106: 1265–72.
Mahajan N. Fertility preservation in female cancer patients: an overview. J Hum Reprod Sci. 2015;8(1):3–13.
Tang M, Webber K. Fertility and pregnancy in cancer survivors. Obstet Med. 2018;11:110–15.
Cohen LE. Cancer treatment and the ovary: the effects of chemotherapy and radiation. Ann N Y Acad Sci. 2008;1135: 123–5.
Winther JF, Svendsen AL, Frederiksen K, Stovall M, Olsen JH. Spontaneous abortion in a Danish population-based cohort of childhood cancer survivors. J Clin Oncol. 2008;26:4340–6.
Chiarelli AM, Marrett LD, Darlington GA. Pregnancy outcomes in females after treatment for childhood cancer. Epidemiology. 2000; 11(2):161–6.
Signorello LB, Cohen SS, Bosetti C, et al. Female survivors of childhood cancer: preterm birth and low birth weight among their children. J Natl Cancer Inst. 2006;98(20):1453–61.
Reulen RC, Zeegers MP, Wallace WH, et al. Pregnancy outcomes among adult survivors of childhood cancer in the British childhood Cancer survivor study. Cancer Epidemiol Biomark Prev. 2009; 18(8):2239–47.
D'Angio GJ, Evans A, Breslow N, et al. The treatment of Wilms' tumor: results of the second National Wilms' tumor study. Cancer. 1981; 47(9):2302–11.
Green DM, Fine WE, Li FP. Offspring of patients treated for unilateral Wilms' tumor in childhood. Cancer. 1982; 49(11):2285–8.
Hawkins MM, Smith RA. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer. 1989;43(3):399–402
Darzy KH, Shalet SM. Hypopituitarism following radiotherapy revisited. Endocr Dev. 2009;15:1–24.
Roth C, Lakomek M, Schmidberger H, Jarry H. Cranial irradiation induces premature activation of the gonadotropin-releasing-hormone (in German). Klin Pediatr. 2001;213:239–43.
Lannering B, Jansson C, Rosberg S, Albertsson-Wikland K. Increased LH and FSH secretion after cranial irradiation in boys. Med Pediatr Oncol. 1997;29: 280–7.
Koustenis E, Pfitzer C, Balcerek M, et al. Impact of cranial irradiation and brain tumor location on fertility: a survey. Klin Padiatr. 2013; 225(6):320–4.
